Table 1 Demographic and clinical data of the studied TDT children
Variable | N = 80 |
|---|---|
Age of start transfusion (years): Mean ± SD | 2.2 ± 2.7 |
Duration of transfusion (years): Mean ± SD | 9.3 ± 5.02 |
BMI: Mean ± SD | 16.6 ± 3.02 |
Iron chelation therapy: | |
Deferoxamine: n (%) | 23 (28.75%) |
Deferasirox: n (%) | 23 (28.75%) |
Deferiprone: n (%) | 9 (11.25%) |
Combined: n (%) | 25 (31.25%) |
Splenectomy: n (%) | 18 (45%) |
Hepatomegaly:: n (%) | 49 (61.25%) |